In Treatment of Bacterial infections Duricef Kid Tablet is an antibiotic medicine that works by killing the infection-causing bacteria in your body. It is effective for bacterial infections of the throat, ears, urinary tract, skin, and soft tissues. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better. Stopping it early may make the infection come back and harder to treat.
Consuming alcohol with Duricef Kid Tablet does not cause any harmful side effects.
Duricef Kid Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Duricef Kid Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoid prolonged use of Duricef Kid Tablet, since it may have possible effects such as rash and diarrhea.
It is not known whether Duricef Kid Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Duricef Kid Tablet should be used with caution in patients with kidney disease. Dose adjustment of Duricef Kid Tablet may be needed. Please consult your doctor.
Duricef Kid Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Duricef Kid Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Duricef Kid Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Apostle Remedies || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Monokem Labs || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mapra Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Synchem Lab || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Stanford Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: New Medicon Pharma Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Troikaa Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)